Management of Chemotherapy-Induced Anemia (CIA) in an Immuno-oncotherapy-Treated Cancer Patient - Dr Debashis Chatterjee Contributed By Dr Debashis Chatterjee12 March 2026 11:23 AM ISTChemotherapy-induced anemia, gallbladder cancer, and immunotherapy management are important clinical challenges in oncology practice. In this video,...
NPPA Panel Rejects Dr Reddy's Omez ODT Plea For Seperate Price, Finds No Therapeutic Edge Farhat Nasim24 July 2025 6:54 PM ISTNew Delhi: In a decisive move against what it viewed as an unjustified price escalation, the Multi-Disciplinary Committee (MDC) under India's drug...
Over Rs 2 Cr Semaglutide Theft at Dr Reddy's Srikakulam Unit, Staff Among 8 Arrested Farhat Nasim13 Jun 2025 6:17 PM ISTSrikakulam: In a serious breach of supply chain and internal controls, a group of eight individuals, including current and former pharmaceutical...
Dr Reddy's Gets Rs 2,395 Crore Tax Notice Over Merger, Says No Material Impact Farhat Nasim2 Jun 2025 12:27 PM ISTNew Delhi: Drug major, Dr. Reddy's Laboratories Ltd. has disclosed that it has received an order from the Income Tax Department under Section 148A(3)...
Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions Farhat Nasim3 May 2025 7:31 PM ISTNew Delhi: Nimesulide, a widely used painkiller in India, is facing renewed regulatory scrutiny over its safety profile, with India's apex drug...
Rs 1 Cr Plus Earners in Firing Line as Dr Reddy's Targets 25% Cost Cut, May Shut Digital Unit Farhat Nasim14 April 2025 6:43 PM ISTHyderabad: In a strategic move to enhance operational efficiency, pharmaceutical giant Dr Reddy's Laboratories (DRL) has initiated a significant cost...
Dr Reddy's Slapped Rs 2,395 Cr Income Tax Notice, Pharma Giant Denies Allegations Farhat Nasim8 April 2025 6:07 PM ISTHyderabad: The Income Tax Department has issued a show cause notice to Dr Reddy's Laboratories Limited, proposing a tax demand exceeding Rs 2,395...
Dr. Reddy's Labs Gets CDSCO Panel Nod To Manufacture, Market Esomeprazole Gastro resistant capsules Written By Dr. Divya Colin9 Feb 2025 6:00 PM ISTNew Delhi: The pharmaceutical major Dr. Reddy's Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central...
CDSCO Panel approves Dr Reddys proposal to increase patients from 241 to 265 in India for anticancer drug Nivolumab study Written By Dr. Divya Colin12 Jan 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Dr Reddy's Laboratories Gets CDSCO Panel Nod To Manufacture, Market Esomeprazole Magnesium Written By Dr. Divya Colin30 Nov 2024 5:30 PM ISTNew Delhi: Reviewing the bioequivalence study report of the gastric drug Esomeprazole Magnesium for delayed release oral suspension 10 mg, the Subject...
Two Dr Reddy's former employees ordered to repay Rs 41L, Rs 39L VRS amounts for reemployment Farhat Nasim12 Nov 2024 5:16 PM ISTHyderabad: Two former employees of Dr Reddy's Laboratories Limited (Dr Reddys) have been directed by the Labour Court-2 in Hyderabad to repay the VRS...
Dr. Reddy's Laboratories Gets CDSCO Panel Nod to Study FDC Telmisartan Plus Chlortalidone for Export purpose only Written By Dr. Divya Colin23 Sept 2024 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
